Michael Thomas Henderson, Chief Business Officer at BridgeBio Pharma, Inc. (BBIO), sold 10,000 shares at $38.33 ($384K) on 2020-11-02, disclosed to the SEC on 2020-11-03.
Open-market sale of $384k BBIO by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.33 | 9,500 | $364K | 94.9% |
| 2 | $38.92 | 500 | $19K | 5.1% |
| Total | $38.36 avg | 10,000 | $384K | 100% |
| Filing → |
| SYRE | SELL | 2026-06-23 | $2.0M | — | Filing → |
| APGE | SELL | 2026-06-12 | $1.7M | — | Filing → |
| APGE | SELL | 2026-05-15 | $1.6M | — | Filing → |